SCCM
TMO icon

Schafer Cullen Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Schafer Cullen Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,446
Closed -$3M – 144
2020
Q4 		$3M Sell
6,446
-6,004
-48% -$2.82M 0.04% 121
2020
Q3 		$5.5M Sell
12,450
-562
-4% -$232K 0.09% 97
2020
Q2 		$4.71M Buy
13,012
+1
+0% +$335 0.07% 103
2020
Q1 		$3.69M Sell
13,011
-2,312
-15% -$729K 0.06% 116
2019
Q4 		$4.98M Sell
15,323
-1,070
-7% -$324K 0.06% 118
2019
Q3 		$4.78M Sell
16,393
-4,370
-21% -$1.25M 0.06% 113
2019
Q2 		$6.04M Sell
20,763
-8,634
-29% -$2.38M 0.07% 106
2019
Q1 		$8.05M Sell
29,397
-322
-1% -$80.1K 0.12% 92
2018
Q4 		$6.65M Sell
29,719
-243
-0.8% -$57K 0.1% 102
2018
Q3 		$7.31M Sell
29,962
-830
-3% -$191K 0.1% 98
2018
Q2 		$6.38M Sell
30,792
-475
-2% -$101K 0.08% 104
2018
Q1 		$6.46M Sell
31,267
-108
-0.3% -$22.7K 0.08% 108
2017
Q4 		$5.96M Sell
31,375
-190
-0.6% -$36.4K 0.07% 112
2017
Q3 		$5.97M Sell
31,565
-610
-2% -$110K 0.07% 107
2017
Q2 		$5.61M Sell
32,175
-7,615
-19% -$1.28M 0.07% 104
2017
Q1 		$6.11M Sell
39,790
-340
-0.8% -$52K 0.08% 106
2016
Q4 		$5.66M Sell
40,130
-150
-0.4% -$22.1K 0.08% 111
2016
Q3 		$6.41M Sell
40,280
-340
-0.8% -$52.4K 0.08% 100
2016
Q2 		$6M Sell
40,620
-835
-2% -$123K 0.07% 100
2016
Q1 		$5.87M Sell
41,455
-580
-1% -$77.7K 0.07% 97
2015
Q4 		$5.96M Sell
42,035
-960
-2% -$128K 0.07% 101
2015
Q3 		$5.26M Sell
42,995
-510
-1% -$66.4K 0.06% 113
2015
Q2 		$5.64M Sell
43,505
-1,080
-2% -$141K 0.06% 128
2015
Q1 		$5.99M Sell
44,585
-732
-2% -$94.4K 0.06% 123
2014
Q4 		$5.68M Sell
45,317
-1,219
-3% -$148K 0.07% 110
2014
Q3 		$5.66M Sell
46,536
-254
-0.5% -$30.9K 0.05% 128
2014
Q2 		$5.52M Sell
46,790
-895
-2% -$105K 0.05% 152
2014
Q1 		$5.73M Sell
47,685
-159
-0.3% -$18.9K 0.06% 138
2013
Q4 		$5.33M Sell
47,844
-189
-0.4% -$18.8K 0.05% 146
2013
Q3 		$4.43M Sell
48,033
-1,144
-2% -$103K 0.05% 162
2013
Q2 		$4.16M Buy
+49,177
New +$4.09M 0.05% 160

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Schafer Cullen Capital Management's TMO Position: Q1 2021 in Review

Schafer Cullen Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2021, closing a stake of 6,446 shares — an estimated $3M sold.

Schafer Cullen Capital Management first reported a position in TMO in Q2 2013 and held it in 31 quarters. The position peaked at $8.05M in Q1 2019. 2,042 funds tracked by Wall St. Rank hold TMO as of Q1 2021.

  • Schafer Cullen Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2021 after selling out during the quarter.
  • Schafer Cullen Capital Management sold 6,446 Thermo Fisher Scientific shares in Q1 2021, an estimated $3M.
  • Schafer Cullen Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 31 quarters.
  • Schafer Cullen Capital Management's Thermo Fisher Scientific position peaked at $8.05M in Q1 2019.
  • 2,042 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.

Based on Schafer Cullen Capital Management's 13F filing for Q1 2021, filed 10 May 2021.